On Thursday, Shares of Wal-Mart Stores, Inc. (NYSE:WMT), subtract -3.22% and closed at $69.36 in the last trading session. The last trading range of the stock ranges between $68.89 and $70.43. At its 2016 Investment Community Meeting recently, Wal-Mart Stores, Inc. (WMT) will outline the company’s planned framework to grow by serving customers across all channels, creating a seamless shopping experience. The company is also sharing select guidance information together with its capital expenditure estimates for the next fiscal year.
Walmart President and CEO Doug McMillon will outline four key areas of focus to drive continued success:
- Make every day easier for busy families;
- Operate with discipline, counting a continued focus on expense administration;
- Be the most trusted retailer; and
- Deliver results and position the company to win.
McMillon noted ongoing success will be driven by a number of factors. These include continued momentum in the U.S. business; solid growth in key international markets, counting Mexico and Canada; a sharpened focus in China; and e-commerce investments.
“We are encouraged by the progress we’re seeing across our business and we’re moving with speed to position the company to win the future of retail. Our customers want us to run great stores, provide a great e-commerce experience and find ways to save them money and time seamlessly – so that’s what we’re doing,” McMillon said.
Skyline Medical Inc (NASDAQ:SKLN), dropped -9.27% and closed at $0.140 in the last trading session. The last trading range of the stock ranges between $0.12 and $0.15. The company’s Market capitalization is $10.87 Million with the total Outstanding Shares of 81.80 Million. Skyline Medical Inc. (SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, declared recently that Dr. Carl Schwartz, Interim Chief Executive Officer of Skyline Medical; Bob Beringer, Chief Executive Officer of Electronic On-Ramp; and Richard Gabriel, Co-founder and Chief Operating Officer of GLG Pharma, LLC. will be interviewed on WPSL’s “MONEYINFO by PRINCETON RESEARCH with MIKE KING and CHARLES MOSKOWITZ” show on Tuesday, September 27th. The show will begin at 10:05 a.m. Eastern time and administration’s interview will begin at 10:20 a.m.
Administration is expected to discuss recent news that Skyline Medical has signed a partnership agreement with GLG, which intends to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures, and its expected joint venture with Electronic On-Ramp to supply STREAMWAY to U.S. government mobile operating rooms, counting disaster relief sites.
Oclaro, Inc. (NASDAQ:OCLR), gained 1.77 % and closed at $9.22 in the last trading session. The last trading range of the stock ranges between $8.94 and $9.25. During the 52-week trading session the minimum price at which share price traded, registered at $1.55 and reached to max level of $165.90M. Oclaro, Inc. (OCLR) declared recently the pricing of its public offering (the “Offering”) of 15,000,000 shares of its common stock at a price to the public of $8.35 per share. In addition, Oclaro has granted the underwriters a 30-day option to purchase up to 2,250,000 additional shares of its common stock. Oclaro anticipates to close the offering on September 27, 2016, subject to customary closing conditions.
Oclaro intends to use the net proceeds from the offering for general corporate purposes, counting working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses. Oclaro does not have agreements or commitments for any specific acquisition at this time.